To keep thoughts moving

Mentalee combines physical and mental training in an innovative app that aims to strengthen cognitive fitness and have a preventive effect
against dementia. With our unique training programs and state-of-the-art technology, we offer users an effective way to keep their body
and mind moving.

Patent application Nr. GB2413046.0

Patent Application in the UK

After the successful demonstration of prototype systems, verification, and field trials last year, this month’s patent application was a logical next step. With this achievement, we are excited to enter a new phase of maturity for both our product and our company.

"Dischingen, Germany – September 7, 2024"

The patent application number GB2413046.0 ("pending" patent) allows us to present our latest developments in digital health technologies. These can now be further expanded, supporting Mentalee’s efforts to play a key role in transforming the healthcare sector.

Our vision and goals remain unchanged:

Mentalee aims to develop innovative solutions that fundamentally change the way neurodegenerative diseases are diagnosed and treated. The main goals of our current project can be summarized as follows:

Disease Prevention and Proactive Health Management:
Mentalee develops technologies that enable patients to independently monitor their health and take early action to prevent chronic diseases. We offer personalized and data-driven healthcare services.

Early Detection and Diagnosis:
Our focus is on supporting the early diagnosis of diseases, significantly improving patient outcomes. With Mentalee, we aim to delay, halt, or even improve the effects of early-diagnosed conditions. Our app is based on the latest scientific findings. Through collaboration with motivational psychologists, Mentalee becomes an engaging experience.

Tailored Treatments:
We strive to develop treatments that are individually tailored to each patient, ensuring that neither under- nor overexertion occurs. Users receive real-time feedback.

Healthcare Transformation:
Mentalee is working on the development of technologies that improve the efficiency and accessibility of healthcare services worldwide. The use of AI and data-driven decision-making is at the core of these efforts, allowing for use anytime, anywhere.

Digital Health Technologies:
Mentalee’s platform offers patients and doctors intuitive tools that allow them to better manage and monitor personalized treatment plans, improving overall health management.

Our patent not only describes the innovative technology we had to develop along the way, but also establishes a framework in which researchers from science, healthcare, and industry can use the same technology to accelerate research in the field of patient movement therapy and offer it on a standard platform. This opens up vast potential for collaboration with like-minded researchers.

This collaboration is important to us, as the saying goes: "Shared pain is half the pain. Shared joy is double the joy." The ability to share knowledge and ideas is at the heart of those who want to make a difference! This milestone not only reflects the success of our product but also paves the way for future innovations. We are excited to announce new features soon that will further enhance the user experience.

To learn more about our product and its latest features, please visit our website at http://www.mentalee.com and feel free to contact us via the contact form or visit us at upcoming workshops, exhibitions, or trade shows.

With a strong focus on research and development, Mentalee is well-positioned to become a leading company in the field of digital healthcare applications in Germany, Europe, and worldwide. The combination of innovative technologies, tailored treatments, and a growing market for digital health solutions offers promising investment opportunities. We believe that we have defined a clear path for the rapid and controlled delivery of proven treatments.

Mentalee is committed to improving both patient care and offering investors long-term growth opportunities. We invite investors to join us on this exciting journey and help shape the future of digital healthcare together with us.

For media or investor inquiries, please contact:

Elke Zihsler
Mentalee UG (limited liability)
Email: team@mentalee.com
Phone: +49 15207887438

For research inquiries, please contact:

Svenja Zihsler
Mentalee UG (limited liability)
Email: team@mentalee.com
Phone: +49 15207887438

Exclusive Prospect Program

Sign up for our exclusive prospect program. You will receive information about the Mentalee app, its benefits when using it, and automatically take advantage of our benefits from the FIRST STARTER program.